Trial Profile
Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines: Active Controlled, Double-blind, Randomized, Multi-center, Phase II/III Clinical Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Mar 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 19 Sep 2016 New trial record